Takeda Pharmaceutical Products

Takeda Pharmaceutical Company Limited is a global, values-based, R&D-driven biopharmaceutical leader. Founded over 240 years ago, the brand began operations in the Doshomachi district of Osaka, Japan, which is historically recognized as the heart of the Japanese pharmaceutical industry. Over the centuries, Takeda has evolved from a local traditional medicine distributor into one of the world's largest pharmaceutical companies.

The brand's production footprint is truly global, with state-of-the-art manufacturing facilities located across Japan, the United States, Europe, and Asia. These facilities specialize in diverse therapeutic areas including oncology, rare diseases, neuroscience, and gastroenterology. Following the massive acquisition of Shire in 2019, Takeda solidified its position as a top-tier global player with a significant presence in the United States and Europe.

As of the mid-2020s, Takeda operates as an independent, publicly traded entity headquartered in Tokyo, Japan. It maintains a primary listing on the Tokyo Stock Exchange and a secondary listing on the New York Stock Exchange. The company continues to prioritize investment in R&D to drive medical innovation, maintaining its status as the largest pharmaceutical company in Japan and one of the most influential in the global healthcare sector.